Skip to main content
Premium Trial:

Request an Annual Quote

In Print: Recent Pharmacogenomics Papers of Note: Jan 15, 2014


Building pharmacogenetics into a pharmacovigilance program in Singapore: using serious skin rash as a pilot study.
Toh DS, Tan LL, Aw DC, et al.
Pharmacogenomics J. 2014 Jan 7. [Epub ahead of print]

Detecting signals in pharmacogenomic genome-wide association studies.
Wakefield J, Skrivankova V, Hsu FC, et al.
Pharmacogenomics J. 2014 Jan 7. [Epub ahead of print]

Overview of diagnostic/targeted treatment combinations in personalized medicine for breast cancer patients.
Tessari A, Palmieri D, Di Cosimo S.
Pharmgenomics Pers Med. 2013 Dec 16;7:1-19.

Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease.
Erlinge D, James S, Duvvuru S, et al.
Thromb Haemost. 2014 Jan 9;111(5). [Epub ahead of print]

Pharmacogenomic characterization of gemcitabine response - a framework for data integration to enable personalized medicine.
Harris M, Bhuvaneshwar K, Natarajan T, et al.
Pharmacogenet Genomics. 2014 Feb;24(2):81-93.

Molecular and Genetic Diversity in the Metastatic Process of Melanoma.
Harbst K, Lauss M, Cirenajwis H, et al.
J Pathol. 2014 Jan 7. [Epub ahead of print]

Assessing the Integration of Genomic Medicine in Genetic Counseling Training Programs.
Profato J, Gordon ES, Dixon S, Kwan A.
J Genet Couns. 2014 Jan 8. [Epub ahead of print]

Approval gap of pharmacogenomic biomarkers and in vitro companion diagnostics between the United States and Japan.
Shimazawa R, Ikeda M.
J Clin Pharm Ther. 2014 Jan 10. [Epub ahead of print]

Targeted therapy pretreatment helps chemotherapy for aggressive lymphoma.
Printz C.
Cancer. 2014 Jan 1;120(1):3.

Pharmacogenetics of methotrexate in acute lymphoblastic leukaemia: why still at the bench level?
Kodidela S, Suresh Chandra P, Dubashi B.
Eur J Clin Pharmacol. 2013 Dec 27. [Epub ahead of print]

Pharmacogenetics: Implications of race and ethnicity on defining genetic profiles for personalized medicine.
Ortega VE, Meyers DA.
J Allergy Clin Immunol. 2014 Jan;133(1):16-26.

Genomics, personalized medicine, and pediatrics.
Feero WG, Guttmacher AE.
Acad Pediatr. 2014 Jan-Feb;14(1):14-22.

Molecularly targeted cancer therapy: some lessons from the past decade.
Huang M, Shen A, Ding J, Geng M.
Trends Pharmacol Sci. 2014 Jan;35(1):41-50. Epub 2013 Dec 19.

What is personalized medicine: sharpening a vague term based on a systematic literature review.
Schleidgen S, Klingler C, Bertram T, et al.
BMC Med Ethics. 2013 Dec 21;14(1):55.

Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets.
Balko JM, Giltnane J, Wang K, et al.
Cancer Discov. 2013 Dec 19. [Epub ahead of print]

Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.
Reynolds GP, McGowan OO, Dalton CF.
Br J Clin Pharmacol. 2013 Dec 19. [Epub ahead of print]

Genetic Profiling to Determine Risk of Relapse Free Survival in High-risk Localized Prostate Cancer.
Barnett CM, Heinrich MC, Lim J, et al.
Clin Cancer Res. 2013 Dec 18. [Epub ahead of print]